(E)-3-(benzo[d] [1,3] dioxol-5-yl)acrylohydrazide | 1362016-80-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (E)-3-(benzo[d] [1,3] dioxol-5-yl)acrylohydrazide
• 英文别名: (E)-3-(1,3-benzodioxol-5-yl)prop-2-enehydrazide
• CAS: 1362016-80-5
• 化学式: C₁₀H₁₀N₂O₃
• mdl: MFCD11643290
• 分子量: 206.201
• InChiKey: MAXKETMQKNTYGT-DUXPYHPUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  73.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (E)-3-(benzo[d] [1,3] dioxol-5-yl)acrylohydrazide 在 sodium hydride 、 溶剂黄146 作用下， 以 1,4-二氧六环 、 N,N-二甲基甲酰胺 为溶剂， 反应 8.08h， 生成
  参考文献：
  名称：

  New daphnane diterpenoidal 1,3,4-oxdiazole derivatives as potential anti-hepatoma agents: Synthesis, biological evaluation and molecular modeling studies

  摘要：

  DOI：

  10.1016/j.bioorg.2024.107208
• 作为产物：
  描述：

  3,4-methylenedioxy-trans-cinnamic acid 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 一水合肼 作用下， 以 乙腈 、 环己烯 为溶剂， 反应 2.0h， 以50%的产率得到(E)-3-(benzo[d] [1,3] dioxol-5-yl)acrylohydrazide
  参考文献：
  名称：

  鉴定为南美锥虫病候选药物的新型功能化碳酰氨基酰胺类化合物的鉴定

  摘要：

  背景：尽管在全球范围内已经进行了许多研究努力，以发现用于治疗南美锥虫病的新型药物，但硝基咪唑药物苯并尼达唑仍然是控制该病的唯一治疗选择。但是，这种药物在慢性疾病中的疗效下降，长期服用后安全性受到限制，因此有必要寻找新的，更有效和安全的原型。 目的：我们在本文中描述了新型功能化糖肼酰胺（2-10）的合成和针对克氏锥虫的锥虫病形式的锥虫杀灭作用。 方法：通过分子杂交技术在两种强效抗T蛋白之间的应用，设计了这些化合物。Cruzi原型，硝基咪唑衍生物megazol（1）和肉桂基N-酰基hydr衍生物（14）在体外的功效是苯硝唑的两倍。 结果：最具活性的化合物是（Z）-N'-（（E）-3-（4-硝基苯基）-丙烯酰基）-1-甲基-5-硝基-1H-咪唑-2-碳酰肼（6）（ IC50 = 9.50μM）和（Z）-N'-（（（E）-3-（4-羟基苯甲基）-丙烯酰基）-1-甲基-5-硝基-1H-咪唑-2-碳酰肼酰胺（8）

  DOI：

  10.2174/1573406415666190627103013

文献信息

• Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives
  作者：Vasiliki Mavrikaki、Alexandros Pagonis、Isabelle Poncin、Ivy Mallick、Stéphane Canaan、Victoria Magrioti、Jean-François Cavalier

  DOI：10.1016/j.bmcl.2022.128692

  日期：2022.5

  their toxicity towards murine macrophages by the resazurin microtiter assay (REMA). Among the 45 derivatives, 17 compounds (3 hydroxamic acids, 9 hydrazides, and 5O-alkyl/O-acyl protected hydroxamic acids) were nontoxic against murine macrophages. When tested for their antibacterial activity, hydroxamic acid 9 h was found to be the most potent inhibitor against M. abscessus S and R only. Regarding hydrazide

  以发现新的抗结核分子为目的，合成了三个新系列的 23 异羟肟酸、13 酰肼和 9O-烷基/O-酰基保护异羟肟酸衍生物，并通过光谱1 H NMR、13 C NMR、HRMS对其进行了全面表征。 ） 分析。通过刃天青微量滴定法 (REMA) 进一步对这些化合物进行了生物筛选，以了解它们对三种致病性分枝杆菌（脓肿分枝杆菌 S 和 R、海分枝杆菌和结核分枝杆菌）的体外抗菌活性，以及​​它们对小鼠巨噬细胞的毒性。 . 在 45 种衍生物中，17 种化合物（3 种异羟肟酸、9 种酰肼和 5O-烷基/O-酰基保护的异羟肟酸）对小鼠巨噬细胞无毒。当测试它们的抗菌活性时，异羟肟酸发现9 小时仅对脓肿分枝杆菌 S 和 R 是最有效的抑制剂。酰肼系列对脓肿分枝杆菌R、海分枝杆菌和结核分枝杆菌的活性仅7h ；而 O- 酰基保护的异羟肟酸衍生物14d和15d对 M. marinum 和 M. tuberculosis
• Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases
  作者：Cindy Juliet Cristancho Ortiz、Caio Miranda Damasio、Letizia Pruccoli、Nathália Fonseca Nadur、Luciana Luiza de Azevedo、Isabella Alvim Guedes、Laurent Emmanuel Dardenne、Arthur Eugen Kümmerle、Andrea Tarozzi、Claudio Viegas

  DOI：10.1007/s11064-020-03148-2

  日期：2020.12

  Abstract A new series of ten multifunctional Cinnamoyl-N-acylhydrazone-donepezil hybrids was synthesized and evaluated as multifunctional ligands against neurodegenerative diseases. The molecular hybridization approach was based on the combination of 1-benzyl-4-piperidine fragment from the anti-Alzheimer AChE inhibitor donepezil (1) and the cinnamoyl subunit from curcumin (2), a natural product with

  摘要 合成了一系列新的十个多功能肉桂酸-N-酰基ep-多奈哌齐杂种，并将其评价为对抗神经变性疾病的多功能配体。分子杂交方法基于抗阿尔茨海默氏病AChE抑制剂多奈哌齐（1）的1-苄基-4-哌啶片段和姜黄素（2）的肉桂酰亚基的组合，姜黄素是具有显着抗氧化剂，神经保护和抗衰老作用的天然产物。N-酰基hydr片段作为间隔子亚基，具有炎性特性。化合物4a和4d对AChE表现出中等抑制作用，IC 50值分别为13.04和9.1 µM。另外，复合图4a和4d显示了与在分子对接研究中观察到的多奈哌齐相似的预测结合模式。另一方面，化合物4a和4c表现出显着的自由基清除活性，对DPPH测试显示出最佳效果，并且还表现出显着的保护性神经元细胞活力，其暴露于t-BuOOH和针对6-OHDA的损伤可防止帕金森氏病的氧化应激疾病。类似地，化合物4c能够防止ROS形成，间接的抗氧化剂活性增加了细胞内GSH水平，并且具有抵
• Piperine–Chlorogenic Acid Hybrid Inhibits the Proliferation of the SK-MEL-147 Melanoma Cells by Modulating Mitotic Kinases
  作者：Carolina Pressete、Flávia Pereira Dias Viegas、Thâmara Gaspar Campos、Ester Siqueira Caixeta、João Adolfo Costa Hanemann、Guilherme Álvaro Ferreira-Silva、Bruno Zavan、Alexandre Ferro Aissa、Marta Miyazawa、Claudio Viegas、Marisa Ionta

  DOI：10.3390/ph16020145

  日期：——

  Melanoma is considered the most aggressive form of skin cancer, showing high metastatic potential and persistent high mortality rates despite the introduction of immunotherapy and targeted therapies. Thus, it is important to identify new drug candidates for melanoma. The design of hybrid molecules, with different pharmacophore fragments combined in the same scaffold, is an interesting strategy for obtaining new multi-target and more effective anticancer drugs. We designed nine hybrid compounds bearing piperine and chlorogenic acid pharmacophoric groups and evaluated their antitumoral potential on melanoma cells with distinct mutational profiles SK-MEL-147, CHL-1 and WM1366. We identified the compound named PQM-277 (3a) to be the most cytotoxic one, inhibiting mitosis progression and promoting an accumulation of cells in pro-metaphase and metaphase by altering the expression of genes that govern G2/M transition and mitosis onset. Compound 3a downregulated FOXM1, CCNB1, CDK1, AURKA, AURKB, and PLK1, and upregulated CDKN1A. Molecular docking showed that 3a could interact with the CUL1-RBX1 complex, which activity is necessary to trigger molecular events essential for FOXM1 transactivation and, in turn, G2/M gene expression. In addition, compound 3a effectively induced apoptosis by increasing BAX/BCL2 ratio. Our findings demonstrate that 3a is an important antitumor candidate prototype and support further investigations to evaluate its potential for melanoma treatment, especially for refractory cases to BRAF/MEK inhibitors.

  黑色素瘤被认为是皮肤癌中最具侵略性的形式，表现出高转移潜力和持续的高死亡率，尽管引入了免疫疗法和靶向治疗，但仍然很重要识别黑色素瘤的新药物候选者。设计混合分子，将不同的药效团片段组合在同一支架中，是获得新的多靶点和更有效的抗癌药物的有趣策略。我们设计了九种带有胡椒碱和绿原酸药效团的混合化合物，并评估它们对黑色素瘤细胞的抗肿瘤潜力，这些细胞具有不同的突变谱系SK-MEL-147、CHL-1和WM1366。我们确定了名为PQM-277（3a）的化合物是最具细胞毒性的化合物，通过改变调控G2/M转换和有丝分裂起始的基因的表达，抑制有丝分裂进程，并促进细胞在前中期和中期的积累。化合物3a下调了FOXM1、CCNB1、CDK1、AURKA、AURKB和PLK1，上调了CDKN1A。分子对接显示，3a可以与CUL1-RBX1复合物相互作用，这种活性对于触发FOXM1转录激活以及G2/M基因表达至关重要。此外，化合物3a通过增加BAX/BCL2比例有效诱导细胞凋亡。我们的研究结果表明，3a是一个重要的抗肿瘤候选原型，并支持进一步研究以评估其在黑色素瘤治疗中的潜力，尤其是对于BRAF/MEK抑制剂难治性病例。
• Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents
  作者：Samir A. Carvalho、Larisse O. Feitosa、Márcio Soares、Thadeu E.M.M. Costa、Maria G. Henriques、Kelly Salomão、Solange L. de Castro、Marcel Kaiser、Reto Brun、James L. Wardell、Solange M.S.V. Wardell、Gustavo H.G. Trossini、Adriano D. Andricopulo、Edson F. da Silva、Carlos A.M. Fraga

  DOI：10.1016/j.ejmech.2012.05.041

  日期：2012.8

  We report herein the synthesis and trypanocidal profile of new (E)-cinnamic N-acylhydrazones (NAHs) designed by exploiting molecular hybridization between the potent cruzain inhibitors (E)-1-(benzo[d] 11,3)dioxol-5-yl)-3-(4-bromophenyl)prop-2-en-1-one and (E)-3-hydroxy-N'-((2-hydroxynaphthalen-1-yl)methylene)-7-methoxy-2-naphthohydrazide. These derivatives were evaluated against both amastigote and trypomastigote forms of Trypanosoma cruzi and lead us to identify two compounds that were approximately two times more active than the reference drug, benznidazole, and with good cytotoxic index. Although designed as cruzain inhibitors, the weak potency displayed by the best cinnamyl NAH derivatives indicated that another mechanism of action was likely responsible for their trypanocide action. (C) 2012 Elsevier Masson SAS. All rights reserved.
• Design, Synthesis, Trypanocidal Activity, and Studies on Human Albumin Interaction of Novel S-Alkyl-1,2,4-triazoles
  作者：Tatiany Franklim、Leonardo Freire-de-Lima、Otávio Chaves、Isabel LaRocque-de-Freitas、Joana da Silva-Trindade、José Netto-Ferreira、Célio Freire-de-Lima、Debora Decoté-Ricardo、José Previato、Lucia Mendonça-Previato、Marco de Lima

  DOI：10.21577/0103-5053.20190033

  日期：——

  Chagas disease is a neglected tropical disease caused by the hemoflagellated parasite Trypanosoma cruzi (Kinetoplastida). The only available drug to treat chagasic patients in Brazil, the nitroheterocycle benznidazole, is effective solely during the acute phase of the infection. There is accordingly a need to develop new therapeutic tools for the treatment of Chagas disease. This work reports the synthesis, trypanocidal evaluation and human serum albumin (HSA) interactions of a novel series of 1,2,4-triazoles. The new derivatives were synthesized via microwave irradiation in good yields. Most compounds showed toxic effects against T. cruzi with low toxicity to host cells. Three S-alkylated-triazoles showed the best activity profile against amastigotes, with half maximal inhibitory concentration (IC50) values of 3.95 +/- 1.41, 4.15 +/- 0.92 and 3.61 +/- 0.65 mu mol L-1, respectively. The interaction between HSA and 3-[(1E, 3E)-4-(1,3-benzodioxol-5-yl)buta-1,3-dien-1-yl]-5-(butylthio)-4-cyclohexyl-4,5-dihydro-1H-1,2,4-triazole was investigated using multiple spectroscopic techniques and molecular docking, revealing that serum albumin is a potential endogenous carrier to this compound in the human bloodstream.